{"log_id": 5611542721184641439, "direction": 0, "words_result_num": 54, "words_result": [{"probability": {"variance": 0.015729, "average": 0.923203, "min": 0.578346}, "location": {"width": 204, "top": 113, "height": 35, "left": 181}, "words": "这类联合治疗的病人"}, {"probability": {"variance": 0.044535, "average": 0.854434, "min": 0.432112}, "location": {"width": 297, "top": 146, "height": 39, "left": 275}, "words": "与安碘酶合用能增心期"}, {"probability": {"variance": 0.034151, "average": 0.836629, "min": 0.395528}, "location": {"width": 472, "top": 174, "height": 46, "left": 234}, "words": "7.维拉帕米可增加卡、环的浓度"}, {"probability": {"variance": 0.038567, "average": 0.844261, "min": 0.367947}, "location": {"width": 725, "top": 206, "height": 57, "left": 271}, "words": "有报道维拉帕米增人对锐的感性(神经海性),药合好时算密切监测"}, {"probability": {"variance": 0.026001, "average": 0.912931, "min": 0.3747}, "location": {"width": 563, "top": 236, "height": 48, "left": 268}, "words": "动物实验提示吸入性通过减少钙离子内流制心管"}, {"probability": {"variance": 0.048921, "average": 0.683036, "min": 0.385116}, "location": {"width": 587, "top": 261, "height": 51, "left": 178}, "words": "拎帕米同时便用时,何断车,过拆心"}, {"probability": {"variance": 0.000426, "average": 0.965486, "min": 0.944839}, "location": {"width": 169, "top": 263, "height": 34, "left": 921}, "words": "离抗"}, {"probability": {"variance": 0.024642, "average": 0.842937, "min": 0.538007}, "location": {"width": 228, "top": 294, "height": 36, "left": 235}, "words": "10.避免同时便用丙"}, {"probability": {"variance": 0.040661, "average": 0.890001, "min": 0.359084}, "location": {"width": 857, "top": 322, "height": 62, "left": 235}, "words": "11.神经肌肉阻滞剂:资料i动物实验研究表明维拉帕米可能增强神经肌肉剂的活"}, {"probability": {"variance": 0.015283, "average": 0.960812, "min": 0.416747}, "location": {"width": 455, "top": 351, "height": 44, "left": 173}, "words": "性。联合使用时维拉帕米或神经肌肉阻滞剂减"}, {"probability": {"variance": 5e-06, "average": 0.99808, "min": 0.993977}, "location": {"width": 137, "top": 409, "height": 31, "left": 136}, "words": "【药物过量】"}, {"probability": {"variance": 0.002, "average": 0.98147, "min": 0.824097}, "location": {"width": 662, "top": 382, "height": 53, "left": 242}, "words": "12丹曲林:两项动物实验研究表明两药伴随使用:可导致心血管虚脱"}, {"probability": {"variance": 0.001841, "average": 0.986897, "min": 0.735264}, "location": {"width": 907, "top": 441, "height": 66, "left": 176}, "words": "使用维拉帕米过量的主要表现为低血压和心动过缓(如房室分离、高度房室传导阻滞、心脏停搏)"}, {"probability": {"variance": 2e-05, "average": 0.998265, "min": 0.974242}, "location": {"width": 678, "top": 471, "height": 52, "left": 126}, "words": "精神错乱、昏迷、恶心、呕吐、肾功能不全、代谢性酸中毒和高血糖等"}, {"probability": {"variance": 0.004228, "average": 0.979788, "min": 0.688075}, "location": {"width": 913, "top": 501, "height": 63, "left": 168}, "words": "对症治疗包括应用阿托品、异丙肾上腺素和心脏起搏治疗及静脉输液、血管收缩剂、钙溶"}, {"probability": {"variance": 0.003374, "average": 0.969684, "min": 0.753804}, "location": {"width": 613, "top": 530, "height": 50, "left": 126}, "words": "10%的氯化钙溶液)、正性朋力药液透析不能清除维拉帕米"}, {"probability": {"variance": 0, "average": 0.999592, "min": 0.999271}, "location": {"width": 140, "top": 560, "height": 36, "left": 129}, "words": "【药理毒理】"}, {"probability": {"variance": 1.5e-05, "average": 0.996604, "min": 0.990055}, "location": {"width": 89, "top": 596, "height": 25, "left": 123}, "words": "药理作用"}, {"probability": {"variance": 0.004846, "average": 0.980644, "min": 0.5994}, "location": {"width": 842, "top": 624, "height": 63, "left": 240}, "words": "1.:盐酸维拉帕米为钙离子拮抗剂。通过调节心肌传导细胞、心肌收缩细胞以及动脉血"}, {"probability": {"variance": 1e-06, "average": 0.999303, "min": 0.993428}, "location": {"width": 763, "top": 650, "height": 59, "left": 164}, "words": "管平滑肌细胞细胞膜上的钙离子内流,发挥其药理学作用,但不改变血清钙浓度"}, {"probability": {"variance": 0.001984, "average": 0.989196, "min": 0.725316}, "location": {"width": 844, "top": 680, "height": 65, "left": 237}, "words": "2.盐酸维拉帕米扩张心脏正常部位和缺血部位的冠状动脉主干和小动脉,拮抗自发的"}, {"probability": {"variance": 1.5e-05, "average": 0.998751, "min": 0.974698}, "location": {"width": 919, "top": 708, "height": 66, "left": 161}, "words": "或麦角新碱诱发的冠状动脉痉挛,增加了冠状动脉痉挛病人心肌氧的递送,解除和预防冠状动脉"}, {"probability": {"variance": 0.004112, "average": 0.986637, "min": 0.579219}, "location": {"width": 908, "top": 736, "height": 66, "left": 159}, "words": "痉挛;维拉帕米减少总外周阻力,降低心肌耗氧量。可用于治疗变异型心绞痛和不稳定型心绞痛"}, {"probability": {"variance": 7.2e-05, "average": 0.997258, "min": 0.948403}, "location": {"width": 843, "top": 767, "height": 66, "left": 234}, "words": "3.维拉帕米减少钙离子内流,延长房室结的有效不应期,减慢传导,可降低慢性心房"}, {"probability": {"variance": 0.005894, "average": 0.986952, "min": 0.4955}, "location": {"width": 918, "top": 795, "height": 66, "left": 157}, "words": "颤动和心房扑动病人的心室率:减少阵发性室上性心动过速发作的频率。通常维拉帕米不影响正"}, {"probability": {"variance": 0.000371, "average": 0.993812, "min": 0.904722}, "location": {"width": 919, "top": 824, "height": 66, "left": 156}, "words": "常的窦性心率,但可导致病窦综合征病人窦性停搏或窦房阻滞:维拉帕米不改变正常心房的动作"}, {"probability": {"variance": 2e-05, "average": 0.998195, "min": 0.978189}, "location": {"width": 921, "top": 853, "height": 68, "left": 153}, "words": "电位或室内传导时间,但它降低被抑制的心房纤维去极化的振幅、速度以及传导的速度,可能缩"}, {"probability": {"variance": 5e-06, "average": 0.998414, "min": 0.992069}, "location": {"width": 918, "top": 882, "height": 68, "left": 154}, "words": "短附加旁路通道的前向有效不应期,加速房室旁路合并心房扑动或心房颤动病人的心室率,甚至"}, {"probability": {"variance": 2e-06, "average": 0.998538, "min": 0.995968}, "location": {"width": 157, "top": 916, "height": 28, "left": 155}, "words": "会诱发心室颤动"}, {"probability": {"variance": 3e-06, "average": 0.999102, "min": 0.990656}, "location": {"width": 829, "top": 945, "height": 61, "left": 242}, "words": "维拉帕米通过降低体循环的血管阻力产生降低血压作用,一般不引起体位性低血压或反"}, {"probability": {"variance": 0, "average": 0.999227, "min": 0.998423}, "location": {"width": 135, "top": 975, "height": 26, "left": 152}, "words": "射性心动过速"}, {"probability": {"variance": 0.000486, "average": 0.993912, "min": 0.870677}, "location": {"width": 877, "top": 1000, "height": 65, "left": 193}, "words": "5.维拉帕米减轻后负荷,抑制心肌收缩,可改善左室舒张功能。在心肌等长或动力性运动"}, {"probability": {"variance": 1e-06, "average": 0.999266, "min": 0.994251}, "location": {"width": 918, "top": 1029, "height": 65, "left": 151}, "words": "中,维拉帕米不改变心室功能正常病人的心脏收缩功能。器质性心脏疾病的病人,维拉帕米的负"}, {"probability": {"variance": 8.2e-05, "average": 0.996829, "min": 0.94339}, "location": {"width": 915, "top": 1057, "height": 67, "left": 150}, "words": "性肌力作用可被降低后负荷的作用抵消,心脏指数无下降。但在严重左室功能不全的病人(例如"}, {"probability": {"variance": 0.004049, "average": 0.987448, "min": 0.561972}, "location": {"width": 917, "top": 1088, "height": 63, "left": 148}, "words": "肺楔压大于20mmHg或射血分数小于30%),或服用β受体阻滞剂或其它心肌抑制药物的病人,可"}, {"probability": {"variance": 5e-06, "average": 0.99766, "min": 0.993233}, "location": {"width": 181, "top": 1119, "height": 31, "left": 148}, "words": "能出现心功能恶化"}, {"probability": {"variance": 0.000453, "average": 0.994245, "min": 0.866916}, "location": {"width": 830, "top": 1148, "height": 62, "left": 235}, "words": "动物试验提示维拉帕米的局部麻醉作用,是普鲁卡因等摩尔的1.6倍。在人体该作用及"}, {"probability": {"variance": 0.000259, "average": 0.988383, "min": 0.964555}, "location": {"width": 136, "top": 1178, "height": 26, "left": 146}, "words": "剂量尚不清楚"}, {"probability": {"variance": 9.5e-05, "average": 0.994875, "min": 0.966127}, "location": {"width": 252, "top": 1204, "height": 36, "left": 142}, "words": "致癌、致突变和生殖毒性"}, {"probability": {"variance": 0.015583, "average": 0.947422, "min": 0.463689}, "location": {"width": 867, "top": 1230, "height": 72, "left": 196}, "words": "维拉帕米无致癌性。艾姆斯试验证实维拉帕米无致突变性。 -Beagle/长拉米三"}, {"probability": {"variance": 0.013523, "average": 0.948194, "min": 0.555693}, "location": {"width": 920, "top": 1260, "height": 65, "left": 142}, "words": "3mg/kg/d,导致透镜状和/或缝线状改变,≥62.5mg/Kg/d时引起症状手的自内人类尚未"}, {"probability": {"variance": 0.013669, "average": 0.947825, "min": 0.447439}, "location": {"width": 919, "top": 1289, "height": 66, "left": 141}, "words": "有因服用维拉帕米而促使白内障形成的报道。雌性鼠未见损害生殖力零人类的生殖力影响尚不"}, {"probability": {"variance": 0.000285, "average": 0.979733, "min": 0.962858}, "location": {"width": 46, "top": 1323, "height": 25, "left": 142}, "words": "明确"}, {"probability": {"variance": 0, "average": 0.999212, "min": 0.998104}, "location": {"width": 164, "top": 1381, "height": 38, "left": 104}, "words": "【药代动力学】"}, {"probability": {"variance": 0, "average": 0.74315, "min": 0.74315}, "location": {"width": 72, "top": 1336, "height": 71, "left": 685}, "words": "平"}, {"probability": {"variance": 1e-06, "average": 0.999439, "min": 0.998137}, "location": {"width": 214, "top": 1389, "height": 40, "left": 762}, "words": "有限公司"}, {"probability": {"variance": 0.02216, "average": 0.945477, "min": 0.364783}, "location": {"width": 650, "top": 1415, "height": 53, "left": 142}, "words": "维拉帕米静脉注射后2分钟(1~5分钟)开始发挥抗心律失作用"}, {"probability": {"variance": 0.011681, "average": 0.96289, "min": 0.473569}, "location": {"width": 556, "top": 1445, "height": 46, "left": 95}, "words": "用持续约2小时,血流动力学作用3~5分钟开始,约持纱"}, {"probability": {"variance": 0.000595, "average": 0.974646, "min": 0.937658}, "location": {"width": 215, "top": 1441, "height": 34, "left": 839}, "words": "5分钟达最大,作"}, {"probability": {"variance": 0.045625, "average": 0.863237, "min": 0.374696}, "location": {"width": 352, "top": 1465, "height": 43, "left": 703}, "words": "20分钟维拉帕米静脉注后代谢迅"}, {"probability": {"variance": 0.034617, "average": 0.858143, "min": 0.384743}, "location": {"width": 958, "top": 1476, "height": 61, "left": 95}, "words": "速,大部分在脏代谢精除孕双指数型,分为早快迪分布想(半衰期约为分钟)和终木缓慢清"}, {"probability": {"variance": 0.013206, "average": 0.944605, "min": 0.477722}, "location": {"width": 949, "top": 1502, "height": 63, "left": 93}, "words": "除相(半衰期为2~5小时).年龄可能影响维拉帕米的药代动力学,老年病人的滑除半衰期可能延长"}, {"probability": {"variance": 0.031798, "average": 0.869004, "min": 0.483609}, "location": {"width": 907, "top": 1533, "height": 60, "left": 147}, "words": "5天内大约70米以代谢物由尿中泄:16%或更多山炎便清除;约3光~4以原型原排出升功"}, {"probability": {"variance": 0.008906, "average": 0.945603, "min": 0.662637}, "location": {"width": 374, "top": 1562, "height": 38, "left": 93}, "words": "能不全时半衰期延长,血浆消除率路"}], "language": 3}